Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2026-01-25 @ 6:02 AM
Study NCT ID:
NCT00266318
Status:
COMPLETED
Last Update Posted:
2008-04-17
First Post:
2005-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy
Sponsor:
Beth Israel Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
164-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |